DocuSign (NASDAQ:DOCU) Upgraded at JPMorgan Chase & Co.

JPMorgan Chase & Co. upgraded shares of DocuSign (NASDAQ:DOCU) from an underweight rating to a neutral rating in a research note issued to investors on Monday morning, Marketbeat.com reports. JPMorgan Chase & Co. currently has $75.00 price target on the stock, up from their previous price target of $70.00.

DOCU has been the topic of a number of other reports. Jefferies Financial Group lifted their price target on DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. UBS Group boosted their target price on DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. Morgan Stanley boosted their target price on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. Robert W. Baird boosted their target price on DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. Finally, JMP Securities restated a “market outperform” rating and issued a $124.00 target price on shares of DocuSign in a research note on Tuesday, January 7th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $92.91.

DocuSign Stock Up 0.8 %

DOCU stock opened at $80.13 on Monday. DocuSign has a twelve month low of $48.70 and a twelve month high of $107.86. The stock’s 50 day moving average is $88.37 and its 200-day moving average is $79.07. The firm has a market capitalization of $16.19 billion, a PE ratio of 16.52, a P/E/G ratio of 6.94 and a beta of 1.02.

Insider Buying and Selling

In related news, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction on Monday, December 16th. The stock was sold at an average price of $94.60, for a total transaction of $50,516.40. Following the transaction, the director now directly owns 7,736 shares in the company, valued at approximately $731,825.60. The trade was a 6.46 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the business’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $94.77, for a total value of $758,160.00. Following the completion of the transaction, the chief financial officer now owns 101,439 shares in the company, valued at $9,613,374.03. The trade was a 7.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 104,422 shares of company stock valued at $9,665,394 over the last 90 days. Company insiders own 1.66% of the company’s stock.

Hedge Funds Weigh In On DocuSign

Several large investors have recently made changes to their positions in the business. Itau Unibanco Holding S.A. bought a new stake in shares of DocuSign in the third quarter worth about $28,000. Kestra Investment Management LLC bought a new stake in shares of DocuSign in the fourth quarter worth about $30,000. Brooklyn Investment Group bought a new stake in shares of DocuSign in the third quarter worth about $33,000. Modus Advisors LLC bought a new stake in shares of DocuSign in the fourth quarter worth about $36,000. Finally, First Horizon Advisors Inc. increased its holdings in shares of DocuSign by 102.6% in the fourth quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock worth $36,000 after purchasing an additional 201 shares during the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.